XML 51 R39.htm IDEA: XBRL DOCUMENT
v3.25.2

Summary of Significant Accounting Policies - Risks and Uncertainties (Details) - Customer - customer | 3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | --- | ---
Jun. 30, 2025 | Sep. 30, 2024 | Jun. 30, 2024 | Sep. 30, 2023 | Jun. 30, 2025 | Jun. 30, 2024 | Sep. 30, 2024 | Sep. 30, 2023 | Dec. 31, 2024
Sales |  |  |  |  |  |  |  |  |
Risk and Uncertainties |  |  |  |  |  |  |  |  |
Number of customers exceeding 10% of benchmark |  | 0 |  | 0 |  |  | 0 | 0 |
Sales | Medicare |  |  |  |  |  |  |  |  |
Risk and Uncertainties |  |  |  |  |  |  |  |  |
Concentration risk (as a percent) | 14.10% |  | 10.30% |  | 14.10% | 10.90% |  |  |
Accounts receivable |  |  |  |  |  |  |  |  |
Risk and Uncertainties |  |  |  |  |  |  |  |  |
Number of customers exceeding 10% of benchmark |  |  |  |  | 0 |  |  |  | 0
Accounts receivable | Medicare |  |  |  |  |  |  |  |  |
Risk and Uncertainties |  |  |  |  |  |  |  |  |
Concentration risk (as a percent) |  |  |  |  | 12.50% |  |  |  | 11.50%

X
- Definition Represents the number of customers. + References No definition available. + Details
Name: | ntra_NumberOfCustomers
Namespace Prefix: | ntra_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=ntra_MedicareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |